Featured Research

from universities, journals, and other organizations

Scientists unravel the cause of rare genetic disease: Goldman-Favre Syndrome explained

Date:
September 7, 2011
Source:
Federation of American Societies for Experimental Biology
Summary:
New research will help ophthalmologists and scientists understand a genetic disease that causes increased susceptibility to blue light, night blindness, and decreased vision called Enhanced S-Cone Syndrome or Goldman-Favre Syndrome. Scientists found that the expression of genes responsible for healthy renewal of rods and cones in the retina was reduced and that this problem originates in the photoreceptors instead of the retinal pigment epithelial layer as once thought.

A new research report published in The FASEB Journal will help ophthalmologists and scientists better understand a rare genetic disease that causes increased susceptibility to blue light, night blindness, and decreased vision called Enhanced S-Cone Syndrome or Goldman-Favre Syndrome. In the report, scientists found that the expression of genes responsible for the healthy renewal of rods and cones in the retina was reduced and that this problem originates in the photoreceptors themselves rather than in the adjacent retinal pigment epithelial layer as once thought.

"This research could help identify therapeutic agents that would prevent, ameliorate or possibly cure these blinding diseases related to defective renewal of retinal cells," said Krzysztof Palczewski, Ph.D., a senior scientist involved in the research and an editorial board member of The FASEB Journal from the Department of Pharmacology in the School of Medicine at Case Western Reserve University, in Cleveland, Ohio. "It is possible that during aging, this process is slowed and such intervention could be important for determining diseases such as age-related macular degeneration."

To make this discovery, researchers studied both human ESCS patients and an ESCS mouse model. They found that phagocytosis, a process that allows for the normal and continual renewal of rods and cones in the retina, was defective. Using RNA-sequencing to identify differences in complete transcriptomes, and cell culture techniques, scientists demonstrated that the phagocytotic defect was due to the ESCS photoreceptors themselves, rather than the adjacent retinal pigment epithelium layer that also is involved in photoreceptor phagocytosis.

"Learning what goes wrong in rare diseases like Enhanced S-Cone Syndrome allows us to understand how vision works at the molecular level," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "This study provides valuable insight into how the eye renews its photoreceptor cells. Knowing that photoreceptor cells affect their own renewal will surely have an impact on other, more common, forms of retinal degeneration."

According to the U.S. National Institutes of Health Office of Rare Diseases, Enhanced S-Cone Syndrome is an inherited eye disease that affects the retina. Within the retina are "red," "blue," and "green" cones allowing people to see colors properly; and rods which allows us to see in dim light. People with Enhanced S-Cone Syndrome are born with an overabundance of blue cones, reduced numbers of red and green cones, and few, if any, functional rods. This leads to an increased sensitivity to blue light, varying degrees of red and green cone vision, night blindness occurring from early life, vision loss, and retinal degeneration.


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. D. Mustafi, B. M. Kevany, C. Genoud, K. Okano, A. V. Cideciyan, A. Sumaroka, A. J. Roman, S. G. Jacobson, A. Engel, M. D. Adams, K. Palczewski. Defective photoreceptor phagocytosis in a mouse model of enhanced S-cone syndrome causes progressive retinal degeneration. The FASEB Journal, 2011; 25 (9): 3157 DOI: 10.1096/fj.11-186767

Cite This Page:

Federation of American Societies for Experimental Biology. "Scientists unravel the cause of rare genetic disease: Goldman-Favre Syndrome explained." ScienceDaily. ScienceDaily, 7 September 2011. <www.sciencedaily.com/releases/2011/08/110831115942.htm>.
Federation of American Societies for Experimental Biology. (2011, September 7). Scientists unravel the cause of rare genetic disease: Goldman-Favre Syndrome explained. ScienceDaily. Retrieved August 31, 2014 from www.sciencedaily.com/releases/2011/08/110831115942.htm
Federation of American Societies for Experimental Biology. "Scientists unravel the cause of rare genetic disease: Goldman-Favre Syndrome explained." ScienceDaily. www.sciencedaily.com/releases/2011/08/110831115942.htm (accessed August 31, 2014).

Share This




More Health & Medicine News

Sunday, August 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins